Actinium Pharmaceuticals HomeAboutTechnologyProduct PipelinePressAbstractsContact
Technology


Actinium Pharmaceuticals’ Technology


Background

Cancer cells originate at one site and spread throughout the body at different rates... (learn more)

Alpha Particles as Cancer Cell Killing Agents

New approaches in the treatment of cancer are necessary to overcome the limited therapeutic efficacy and high costs of currently available therapeutics... (learn more)

A Comparison of Alpha And Beta Emitters
Use of alpha-particles as the cancer killing agents instead of beta rays is more attractive for a combination of reasons... (learn more)

Components Of Alpha Particle Immunotherapy
There are three principle contributing components, which must be coordinated and managed for successful development and commercialization of alpha particle immunotherapy technology... (learn more)

Assembly of Bi-213 based Alpha Particle Immunotherapies
The antibody/ chelator complex is produced under Good Manufacturing Practices (GMP) ensuring consistent stability and quality... (learn more)

<BACK TO TOP >